Less fluid during robotic prostate surgery? new study seeks the sweet spot
NCT ID NCT07626151
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how much fluid patients should receive during robotic prostate surgery. It compares a standard approach with a more restricted one, using a non-invasive heart monitor to guide decisions. The goal is to see which method keeps tissues better perfused, measured by blood lactate and kidney function. 90 men undergoing robotic prostatectomy will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help establish better fluid management guidelines for robotic prostate surgery, potentially reducing complications like fluid overload or kidney injury.
- What could go wrong
- This is a small, early-stage study (90 participants) focused on short-term outcomes like lactate levels, not long-term survival or cure. Results may not apply to all patients or surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLUID OVERLOAD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cairo University Hospitals
RECRUITINGCairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- Brain-Tracking anesthesia: a faster, smoother Wake-Up?
- AI coaches doctors on cancer risk talks